SEC Comment Letter 0000000000-22-013425 to Monogram Technologies Inc. (MGRM) (CIK 0001769759)
Monogram Technologies Inc. (MGRM) (CIK 0001769759)
Date: Dec. 13, 2022 · CIK: 0001769759 · Accession: 0000000000-22-013425
AI Filing Summary & Sentiment
File numbers found in text: 024-12084
Letter
United States securities and exchange commission logo December 13, 2022 Benjamin Sexson Chief Executive Officer Monogram Orthopaedics Inc. 3913 Todd Lane Austin, TX 78744 Re:Monogram Orthopaedics Inc. Offering Statement on Form 1-A Filed November 29, 2022 File No. 024-12084 Dear Benjamin Sexson: We have conducted a limited review of your offering statement and do not have any comments. We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257 of Regulation A requires you to file periodic and current reports, including a Form 1-K which will be due within 120 calendar days after the end of the fiscal year covered by the report. Please contact Conlon Danberg at 202-551-4466 or Margaret Schwartz at 202-551- 7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Andrew Stephenson, Esq.
Show Raw Text
United States securities and exchange commission logo
December 13, 2022
Benjamin Sexson
Chief Executive Officer
Monogram Orthopaedics Inc.
3913 Todd Lane
Austin, TX 78744
Re:Monogram Orthopaedics Inc.
Offering Statement on Form 1-A
Filed November 29, 2022
File No. 024-12084
Dear Benjamin Sexson:
We have conducted a limited review of your offering statement and do not have any
comments.
We will consider qualifying your offering statement at your request. If a participant in
your offering is required to clear its compensation arrangements with FINRA, please have
FINRA advise us that it has no objections to the compensation arrangements prior to
qualification.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257
of Regulation A requires you to file periodic and current reports, including a Form 1-K which
will be due within 120 calendar days after the end of the fiscal year covered by the report.
Please contact Conlon Danberg at 202-551-4466 or Margaret Schwartz at 202-551-
7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Andrew Stephenson, Esq.